SCHEMBL10016147

SCHEMBL10016147

BC(B)I

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8967183 0.83
SCHEMBL18306916 0.72
SCHEMBL13792671 0.72
SCHEMBL2055282 0.72
SCHEMBL15003922 0.72
SCHEMBL4546305 0.61
SCHEMBL333801 0.58
SCHEMBL6747842 0.55
Iodoform SCHEMBL28140705 0.55
Iodoform SCHEMBL27906049 0.55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119735606-A Preparation method of gem-bis (boron group) -containing cyclopropane compound 南京工业大学 2025-04-01 CN disclosed
CN-119684338-A Gamma-iodo allyl diboron ester compound and preparation method and application thereof 南京工业大学 2025-03-25 CN disclosed
US-8148089-B2 Alpha-synuclein kinase ELAN PHARMA INTERNATIONAL LIMITED (IE) 2012-04-03 US disclosed
US-20110207796-A1 ALPHA-SYNUCLEIN KINASE ELAN PHARMA INTERNATIONAL LIMITED 2011-08-25 US disclosed
US-20100143946-A1 ALPHA-SYNUCLEIN KINASE ELAN PHARMA INTERNATIONAL LIMITED (IE) 2010-06-10 US disclosed
US-20080300206-A1 Alpha-Synuclein Kinase ELAN PHARMACEUTICALS, INC. (US) 2008-12-04 US disclosed